Targeting COPD: from mechanistics to therapeutics

DAY 1

Chaired by: Dr Neil Greening (Leicester) and Dr Nicola Smallcombe (London)

10:45am	From mechanism to medicine: pathways for targeted therapy in COPD Professor Francesca Polverino (USA)
11:15am	Should we focus on alarmins in COPD treatment? Professor Chris Brightling (Leicester)
11:45am	Biologics in COPD: what the new BTS clinical statement means for practice Dr Anthony Martinelli (Cambridge)

10:45 AM

90 MINUTE SESSION

Learning objectives

To understand how advances in COPD pathophysiology are shaping the development of targeted therapies.
To assess the potential of alarmins as therapeutic targets in COPD.
To review how the latest BTS guidance informs the practical use of biologics in COPD care.